or Try an Advanced Search...

    Technical Analysis for SRZN - Surrozen, Inc.

    Grade Last Price % Change Price Change
    F 8.90 -12.40% -1.26
    SRZN closed down 12.4 percent on Wednesday, November 20, 2024, on 1.91 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SRZN trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    200 DMA Resistance Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Multiple of Ten Bearish Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for SRZN ...

       Recent Intraday Alerts

    Alert Time
    Gapped Down (Partial) about 22 hours ago
    10 DMA Support about 22 hours ago
    50 DMA Support about 22 hours ago
    2x Volume Pace about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SRZN Chart by TradingView
    Basic chart:

    Profile

    Surrozen, Inc., a biopharmaceutical company, develops targeted regenerative antibodies to repair a range of tissues and organs damaged by serious disease, and to improve organ function. The company provides antibody platforms that functions as Wnt and R-spondin mimetics in stimulating cell and organ-specific tissue regeneration. Its programs include SZN-043, a liver-specific R-spondin-mimetic to stimulate hepatocyte regeneration in acute and chronic liver disease; and SZN-1326, an intestine-specific Wnt-mimetic to repair diseased epithelial tissue and address an unmet need in patients with inflammatory bowel disease. Surrozen, Inc. was incorporated in 2015 and is based in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Immunology Antibodies Antibody Inflammatory Bowel Disease Glycoproteins Organs Senescence Gastrointestinal Tract Liver

    Is SRZN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 6 Surrozen to Present at Upcoming Healthcare Investor Conferences
    Nov 6 Surrozen GAAP EPS of -$0.44
    Nov 6 Surrozen Provides Third Quarter 2024 Financial Results and Business Update
    Sep 24 Surrozen earns $10M milestone payment through Boehringer collaboration
    Sep 24 Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration
    Aug 15 Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky
    Aug 13 Surrozen GAAP EPS of -$7.99
    Aug 12 Surrozen Provides Second Quarter 2024 Financial Results and Business Update
    Jun 12 Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
    Jun 10 Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
    See more SRZN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.19
    52 Week Low 5.9999
    Average Volume 23,785
    200-Day Moving Average 10.29
    50-Day Moving Average 10.15
    20-Day Moving Average 10.28
    10-Day Moving Average 9.52
    Average True Range 1.28
    RSI (14) 43.50
    ADX 13.28
    +DI 21.49
    -DI 17.25
    Chandelier Exit (Long, 3 ATRs) 10.34
    Chandelier Exit (Short, 3 ATRs) 11.94
    Upper Bollinger Bands 12.83
    Lower Bollinger Band 7.73
    Percent B (%b) 0.23
    BandWidth 49.65
    MACD Line -0.33
    MACD Signal Line -0.14
    MACD Histogram -0.1923
    Fundamentals Value
    Market Cap 18.14 Million
    Num Shares 2.04 Million
    EPS -17.40
    Price-to-Earnings (P/E) Ratio -0.51
    Price-to-Sales 1.43
    Price-to-Book 0.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.41
    Resistance 3 (R3) 11.62 11.00 10.99
    Resistance 2 (R2) 11.00 10.36 10.89 10.85
    Resistance 1 (R1) 9.95 9.97 9.64 9.74 10.71
    Pivot Point 9.33 9.33 9.18 9.22 9.33
    Support 1 (S1) 8.28 8.69 7.97 8.07 7.09
    Support 2 (S2) 7.66 8.30 7.55 6.95
    Support 3 (S3) 6.61 7.66 6.81
    Support 4 (S4) 6.40